South Florida Hospital News
Saturday November 17, 2018

test 2

February 2018 - Volume 14 - Issue 8




Leading Addiction Researcher and New Drug Discovery Scientist Joins FAU

Lawrence Toll, Ph.D., a renowned scientist whose research focuses on the management of pain and drug addiction through pharmacology and new drug discovery, recently joined Florida Atlantic University as a professor in the Department of Biomedical Science in the Charles E. Schmidt College of Medicine and as an investigator in the FAU Brain Institute.

Toll’s ground-breaking research on opioid-related systems, and nicotinic acetylcholine receptors, as well as his identification and characterization of endogenous neuropeptides, have opened new avenues of research and identified novel drug targets. He is internationally recognized as the co-discoverer of the endogenous neuropeptide, nociception, which plays a role in the regulation of reward and motivation pathways related to substance abuse.
Prior to joining FAU, Toll served as the director of the neuropharmacology program at Torrey Pines Institute for Molecular Studies. He is a member of the Society for Neuroscience and American Society for Pharmacology and Experimental Therapeutics and serves as vice president/treasurer and president elect (term to begin in June) of the International Narcotics Research Conference. He is the current chair of the Opioid Receptor Subcommittee of the nonprofit International Union of Basic and Clinical Pharmacology.
Share |